Literature DB >> 6171256

Size characteristics of human leucocyte interferon under reducing and non-reducing conditions.

I A Braude, L S Lin, W E Stewart.   

Abstract

Sodium dodecyl sulphate/polyacrylamide-gel electrophoresis was used to characterize human leucocyte interferon (HuIFN-alpha) under reducing and non-reducing conditions. Under non-reducing conditions HuIFN-alpha possesses two size forms, but under reducing conditions (r-HuIFN-alpha) only one is observed. The apparent molecular weight of this one form varies with the concentration of 2-mercaptoethanol used. When r-HuIFN-alpha is permitted to reoxidize the bimodal configuration of HuIFN-alpha is restored. The size heterogeneity of native HuIFN-alpha can be eliminated by mild treatment with NaIO4 [HuIFN-alpha/IO4; Stewart II, Lin, Wiranowska-Stewart & Cantell (1977) Proc. Natl. Acad. Sci. U.S.A. 74, 4200-4204]. The size of the HuIFN-alpha/IO4 increases after treatment with 2-mercaptoethanol (r-HuIFN-alpha/IO4) and the apparent molecular weight of this component also varies with the concentration of 2-mercaptoethanol used. In the case of r-HuIFN-alpha the single peak observed apparently originates from both the higher- and lower-molecular-weight components.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171256      PMCID: PMC1162689          DOI: 10.1042/bj1930947

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity.

Authors:  W E Stewart; J Desmyter
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells.

Authors:  J Desmyter; W E Stewart
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

3.  Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage.

Authors:  W E Stewart; L S Lin; M Wiranowska-Stewart; K Cantell
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Distinct molecular species of interferons.

Authors:  W E Stewart
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

5.  Stabilisation of interferons by defensive reversible denaturation.

Authors:  W E Stewart; E De Clercq; P De Somer
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

6.  Human leukocyte interferon: a role for disulphide bonds.

Authors:  K E Mogensen; K Cantell
Journal:  J Gen Virol       Date:  1974-01       Impact factor: 3.891

7.  The nucleotide sequence of a cloned human leukocyte interferon cDNA.

Authors:  N Mantei; M Schwarzstein; M Streuli; S Panem; S Nagata; C Weissmann
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

Review 8.  Human leukocyte interferon: production, purification, stability, and animal experiments.

Authors:  K Cantell; S Hirvonen; K E Mogensen; L Pyhälä
Journal:  In Vitro Monogr       Date:  1974

9.  Purification and characterization of human leukocyte interferon components.

Authors:  E T Törmä; K Paucker
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

10.  Biological properties of human leukocyte interferon components.

Authors:  K Paucker; B J Dalton; E T Törmä; C A Ogburn
Journal:  J Gen Virol       Date:  1977-05       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.